Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

PepsiCo, Moderna Rise in Premarket; Gig Economy Stocks Stabilize

Published 13/10/2022, 12:22 am
© Reuters.

By Geoffrey Smith

Investing.com -- Stocks in focus in premarket trade on Wednesday, 12th October. Please refresh for updates.

  • PepsiCo (NASDAQ:PEP) stock rose 2.5% after the drinks and snacks giant beat expectations on top and bottom line thanks to strong price increases across the world that cushioned the impact of the strong dollar. The figures underline how much of the recent rise in inflation has been driven by corporate pricing power.
  • Gig economy stocks steadied after sliding over 12% in some cases on Tuesday in response to an initiative from the Biden administration to class gig workers as employees, something that will significantly increase the cost of the services that companies like Uber (NYSE:UBER) get from their drivers. Uber stock was up 0.9%, while Lyft (NASDAQ:LYFT) stock – which fell over 12% on Tuesday, rebounded 3.5%.
  • DoorDash (NYSE:DASH) stock, another gig economy company, rose 0.5% after falling a more modest 5.9% on Tuesday.
  • KnowBe4 (NASDAQ:KNBE) stock rose 12.5% after a Wall Street Journal report said the company was in advanced talks to sell itself to private equity house Vista Equity for $4.5 billion.
  • LVMH ADRs (OTC:LVMUY) rose 1.6% after the French luxury giant announced its sales rose nearly 20% on the year in the third quarter, thanks largely to free-spending American tourists who returned to Europe in large numbers this summer. It noted that spending at its jewelry unit Tiffany slowed, however.
  • Koninklijke Philips ADRs (NYSE:PHG) slumped 11.7% after the Dutch-based maker of medical devices said it expects a 5% decline in sales and a much sharper drop in underlying earnings in the current quarter. It’s also writing down its sleep-apnea business by $1.3 billion after a mass recall of devices meant to stop snoring.
  • Moderna (NASDAQ:MRNA) stock rose 13.6% on anticipation of a wave of buying of its COVID-19 booster shot after sharp rises in case numbers in Europe and North America at the start of autumn.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.